Johns Hopkins University

Unm Rainforest Innovations

Vaxine Pty Ltd

Fidel P Zavala

Bryce Chackerian

David S Peabody

Nikolai Petrovsky

Lucia Jelinkova

Lucie Jelinkova

An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NPDPNANPNVDPNAN (amino acids 5-19 of SEQ ID NO:1) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria.

Malaria immunogen and methods for using same

An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria. Alternatively, the immunogen may be administered to an individual having or at risk of havingblood stage parasitemia. In some cases, the immunogen can be administered in combination with another therapeutic agent for treating malaria ofblood stage parasitemia.

Growing community of inventors

Baltimore, MD, United States of America

Fidel P Zavala